The Biotech Edge: How Executives and Well-Connected Investors Make Exquisitely Timed Trades in Health Care Stocks
Secret IRS records reveal dozens of highly fortuitous biotech and health care trades.
Never-before-seen IRS records show that CEOs are sometimes making multimillion-dollar bets on the stocks of direct competitors and partners — and doing so with exquisite timing.
Private equity firms have grown substantially since the 1980s and now manage more than $6 trillion in assets in the United States. Their presence has affected industries from hospitals to fisheries.
After a year of reporting on the tax machinations of the ultrawealthy, ProPublica spotlights the top tax-avoidance techniques that provide massive benefits to billionaires.
New details have emerged about the now-closed investigation, including repeated calls to his brother-in-law, who also dumped stock.